The potential of the UK’s “world-leading scientists, innovators and tech firms” is being “squandered”, Ms Lopez said, adding: “The loss of major pharmaceutical deals, including AstraZeneca’s decision to pause its planned £200 million investment in Cambridge, is a damning indictment of Labour’s failure to provide a stable and competitive business environment.”
